Can respiratory muscle training therapy effectively manage obstructive sleep apnea syndrome after stroke?: A protocol of systematic review and meta-analysis
| Autor: | Xiong-Fei Zhao, Liang Yu, Shu-Wen Guo, Chang-Fei Dai |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Research design
safety medicine.medical_specialty MEDLINE effectiveness obstructive sleep apnea syndrome Cochrane Library Breathing Exercises law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Meta-Analysis as Topic law Study Protocol Systematic Review Medicine Humans 030212 general & internal medicine Intensive care medicine Stroke Sleep Apnea Obstructive business.industry respiratory muscle training Sleep apnea General Medicine medicine.disease Obstructive sleep apnea Treatment Outcome Research Design 030220 oncology & carcinogenesis Meta-analysis business Systematic Reviews as Topic Research Article |
| Zdroj: | Medicine |
| ISSN: | 1536-5964 |
| Popis: | Background: This study will explore the effectiveness and safety of respiratory muscle training therapy (RMTT) for the treatment of patients with obstructive sleep apnea syndrome (OSAS) after stroke. Methods: In this study, we will systematically and comprehensively search Cochrane Library, PubMed, EMBASE, WANGFANG, VIP, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure for relevant literature from their inception to March 1, 2020 without any limitations to language and publication status. We will consider any randomized controlled trials focusing on the effectiveness and safety of RMTT for the treatment of patients with OSAS after stroke. The study quality will be checked using Cochrane risk of bias tool, and statistical analysis will be performed utilizing RevMan 5.3 software. Results: This study will summarize and synthesize the current evidence of RMTT for the treatment of patients with OSAS following stroke. Conclusion: The findings of this study will assess the present evidence for the benefits and harms of RMTT for treating OSAS after stroke, and will inform clinical practice and future research. PROSPERO registration number: PROSPERO CRD42020170355. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|